These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6086789)

  • 1. [A cytological study of peritoneal fluid obtained in gynecological laparotomies--with special reference to the diagnosis of ovarian malignancy].
    Fujimaru J; Sato S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):917-26. PubMed ID: 6086789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An application of cytology for ovarian tumors].
    Saito M
    Rinsho Byori; 1992 Feb; 40(2):156-62. PubMed ID: 1583788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Living cytology in the diagnosis of malignant ovarian tumor].
    Tanaka Y; Ueda G; Hiramatsu K; Inoue Y; Saito J; Nishino T; Sato Y; Yamasaki M; Inoue M; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):934-8. PubMed ID: 6875345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
    Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
    Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis.
    Covell JL; Carry JB; Feldman PS
    Acta Cytol; 1985; 29(3):310-6. PubMed ID: 3859128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological and clinical classification of gynecological tumours].
    Moriwaki S
    Gan No Rinsho; 1990 Aug; 36(10):1095-105. PubMed ID: 2214145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
    Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cytological classification of ovarian tumors].
    Ali-Zade VA
    Arkh Patol; 1990; 52(8):23-8. PubMed ID: 2177967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of immunocytochemistry to the cytologic study of peritoneal fluids in patients with ovarian cancer.
    Shinozuka T; Ebisawa K; Miyamoto T; Murakami M; Fujii A; Osamura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1355-62. PubMed ID: 1955789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease.
    Luesley DM; Williams DR; Ward K; Redman CR; Lawton FG
    Acta Cytol; 1990; 34(4):539-44. PubMed ID: 2375222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic features of ovarian tumors of low malignant potential in peritoneal fluids.
    Johnson TL; Kumar NB; Hopkins M; Hughes JD
    Acta Cytol; 1988; 32(4):513-8. PubMed ID: 3400392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of peritoneal fluid in ovarian cancer patients.
    Parrella P; Zangen R; Sidransky D; Nicol T
    Mod Pathol; 2003 Jul; 16(7):636-40. PubMed ID: 12861058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
    Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.
    van de Molengraft FJ; van 't Hof MA; Herman CJ; Vooijs PG
    Anal Quant Cytol; 1982 Sep; 4(3):217-20. PubMed ID: 7149486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms.
    Ziselman EM; Harkavy SE; Hogan M; West W; Atkinson B
    Acta Cytol; 1984; 28(2):105-10. PubMed ID: 6583966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.